NSECertificate under SEBI (Depositories and Participants) Regulations, 20189 Oct 2026 · 9 Oct 2026, 04:57 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Pfizer Limited · PFIZER
✦ AI SummaryRegulatory
Pfizer Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Pfizer Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
PFIZER_09102026165731_SEintimation.pdf
View document text
Pfizer Limited
The Capital, 1802/1901,
Plot No. C - 70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051.
Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
October 9, 2026
The Corporate Relationship Dept. The Manager, Listing Dept.
BSE Limited The National Stock Exchange of India Ltd.
1st Floor, P.J.Towers Exchange Plaza, 5th Floor, Plot No. C/1,
Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E)
Mumbai – 400 001 Mumbai – 400 051
Scrip Code: 500680 Scrip Symbol: PFIZER
Dear Sir / Madam,
Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018 for the quarter ended September 30, 2026.
We furnish herewith certificate dated October 8, 2026, issued by KFin Technologies
Limited, Registrar & Share Transfer Agent of the Company, confirming compliance with
Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter
ended September 30, 2026.
Request you to please take the above on record.
Thanking you,
Yours truly,
For Pfizer Limited
Prajeet Nair
Director – Corporate Services & Company Secretary
Encl.: A/a
CIN: L24231MH1950PLC008311
Email ID: contactus.india@pfizer.com
Website: www.pfizerltd.co.in
KFIN/PFZ/SEP/2026
October 8, 2026
Mr. Prajeet Nair
Director Corporate Services & Company Secretary
M/s. Pfizer Limited
The Capital, 1802/1901 Plot C-70
G Block, Bandra Kurla Complex
Bandra East, Mumbai- 400051
Dear Sir,
Sub: Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, as
amended, for the quarter ended 30th September 2026.
With reference to the Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, as amended, we
hereby confirm that we have complied with the following actions within 15 days of receipt of share certificate(s)
from the Depository Participants for the purpose of dematerialization for the quarter ended September 30, 2026.
Confirmed (approved/rejected) dematerialization request.
The shares comprised in the certificate(s) dematerialized are listed on the Stock exchange(s) where the earlier
issued shares are listed.
Mutilated and cancelled the share certificate(s)forwarded by the Depository Participants.
Substituted the name of depository as the registered owner in our records.
Further, we have been certifying the same to the Depositories and Stock Exchanges in accordance with Regulations.
Thanking You
Yours faithfully,
For Kfin Technologies Limited
Vagolu Ratna Babu
Assistant Vice President